Digitalis has played a prominent role in the therapy of congestive heart failure since William Withering codified its use in 1785, the mechanisms of action of digitalis have been under extensive investigation for nearly 50 years, yielding one of the most specific mechanisms thus far defined for any agent so extensively used. Its ability to bind to and inhibit the Na-K-ATPase (NKA) has been well established, as has the resulting increase in cellular [Ca 2ϩ ] responsible for its positive inotropic action and its toxicity as well. However, recent observations suggest that digitalis has additional effects, such as the positive inotropic effect on heart muscle, and the inductive effect on cell growth, either hypertrophic on heart muscle cells or proliferative on vascular smooth muscle cells.
] responsible for its positive inotropic action and its toxicity as well. However, recent observations suggest that digitalis has additional effects, such as the positive inotropic effect on heart muscle, and the inductive effect on cell growth, either hypertrophic on heart muscle cells or proliferative on vascular smooth muscle cells. 1) The inductive effect of cell proliferation by nontoxic concentrations of digitalis has been observed by Christen and Dornand in studies on cell growth inducers for lymphocytes since 1975, 2, 3) and reports have published that ouabain exerts dual effects (proliferation and death) on cell growth at different concentration in different cell lines. 4, 5) Some researchers proposed the mechanism for ouabain's proliferative inductive effect is its interaction with NKA; this interaction occurred at concentrations that did not induce enzyme activity inhibition and that transformed it into a signal transducer system. 4, 6) However, experimental evidence has been put forward showing that the effect of ouabain on cell survival and proliferation may be either independent of or dependent on the inhibition of cation transport. 7, 8) All of these data indicate that there maybe exist other target sites of digitalis in different cell lines besides NKA, and these target proteins play important roles in the regulation of cell growth and transformation with or without interaction with NKA.
In this study we focused on the effect of low doses of ouabain on proliferation in endothelial cells and did the differential proteomic analysis of human umbilical vein endothelial cells (HUVEC) in response to low-dose ouabain. We compared the different protein expression of control cells and ouabain-treated cells and identified thirty-two proteins, in comparison with controls cells, the differential proteomic analysis of HUVEC treated by ouabain further revealed the variation of eight proteins regulated by ouabain treatment and expression of five of the protein spots increased and that of three proteins decreased. This new information gives new sights into the mechanisms for the proliferative effect of digitalis on HUVEC and provides potential avenues for the development of future therapeutic interventions for the treatment of cardiovascular diseases.
MATERIALS AND METHODS

Materials
Ouabain and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) were purchased from Sigma (U.S.A.), Human umbilical vein endothelial cells (HUVEC) were obtained from American Type Culture Collection (U.S.A.), cell culture medium was from Gibco (U.S.A.), 2-DE reagents were obtained from Amersham Biosciences (U.S.A.) respectively unless otherwise indicated, mouse monoclonal IgG antibody to MRLC2 was provided by Sigma-Aldrich, secondary antibody goat antimouse IgG was purchased from Santa Cruz Biotechnology, and all the other chemicals used were of the highest grade available commercially.
Cell Culture The HUVEC were maintained in complete Bei-An YOU, a and Mei CHENG medium M199 containing 10% FBS, 5 ng/ml bFGF, 25 U/ml heparin, 4 mM L-glutamine, 100 U/ml penicillin-G, and 100 U/ml streptomycin. Cells were cultured in Costar flasks and subconfluent cells were detached with 0.05% trypsin and 0.02% EDTA in calcium-free phosphate buffered saline, counted in hemocytometers and plated at 3ϫ10 3 in 100 ml cultured in 96-well plate (for cell viability assay), or 75 cm 2 Petri dish (for electron microscope and 2-DE) in complete M199 without bFGF. HUVEC were grown in complete medium until reached about 80% of confluency and in most cases such cells were used for the assays. Ouabain was dissolved in DMSO and diluted so that the final concentration of DMSO was Ͻ0.1%, all the control cells were treated with same volume of DMSO, which caused no effect on cell growth.
Cell Viability Analysis To examine the effects of the ouabain on HUVEC proliferation, cells were harvested by trypsinization and cell viability was measured by microscopic examination of trypan blue dye exclusion. Cell survival was estimated with MTT colorimetric assay. HUVEC (2ϫ10 6 cells/ml) were incubated in 24-well plastic culture plates for 12, 24 and 48 h at 37°C in the presence or absence of different concentrations of ouabain, MTT was added at a final concentration of 0.5 mg/ml. After being incubated at 37°C for an additional 4 h, cells were centrifuged at 1000 rpm for 10 min and all the supernatants were discarded, the cells were dissolved in 120 ml isobutanol (containing 0.04 mol/l HCl) and the absorbance was read at 570 nm, results are presented as the average absorbance and expressed as the mean of six samples.
Morphology Examination To evaluate changes in morphology, cells under the effect of ouabain were visualized by transmission electron microscope (TEM). Logarithmic phase cells were trypsinized and plated to the subconfluent density of 10 6 /ml in 75 cm 2 Petri dish and harvested after incubated with different concentrations of ouabain. The cells were fixed in 2.5% glutaraldehyde (v/v) and 2% osmium tetroxide (w/v), washed in PBS, post-fixed in osmium tetroxide, dehydrated in an ethanol series, embedded in epoxy resin, and examined under a Hitachi-700 TEM.
Protein Sample Preparation Following stimulation was achieved by incubation with ouabain 10 nM for 24 h in M199, 1ϫ10 7 cells were added to 100 ml lysis buffer (8 mol/l urea, 4% CHAPS, 40 mmol/l Tris base). After a few cycles of quick freezing and subsequent thawing in liquid nitrogen, 4 ml RNase (10 g/l) was added. After deposition for 20 min, the cells were centrifuged at 12000 g for 30 min. The supernatant was transferred to a new Eppendorf tube and stored. Protein concentrations were assessed using the protein assay PlusOne 2-D Quant kit with BSA as the standard, then the sample were divided into different EP centrifuge tube and preserved at Ϫ80°C. Two-Dimensional Gel Electrophoresis Two-dimensional electrophoresis (2-DE) and image analysis were performed as previously reported with minor modifications. 9) In brief, isoelectric focusing (IEF) was carried out on an IPGphor using precast gel strips. After IEF, strips were equilibrated twice for 10 min in equilibration buffer containing 6 M urea, 30% v/v glycerol, 2% w/v SDS (Bio-Rad) in 50 mM Tris-HCl buffer, pH 6.8, supplemented with: (1) 60 mM DTT for the first treatment and (2) 259 mM iodoacetamide and a trace of bromophenol blue for the second treatment. Running conditions for horizontal SDS-PAGE were 20-50 mA for approximately 2 h.
Gel Staining and Spot Analysis Gels were stained with silver according to Yan JX had reported. 10) Briefly, the gels were fixed in 50% ethanol and 5% acetic acid and then sensitized in 0.02% sodium thiosulfate. The staining was performed in 0.1% silver nitrate. Dried 2-D gels were scanned using GS-800 Calibrated Densitometer (Bio-Rad) and image analysis as well as comparative studies were performed using the PDQuest Image Analysis software (Bio-Rad). After background subtraction, normalization, and matching, the spot volumes in gels from each control cells were compared with the matched spot volumes in gels from ouabain-treated cells. Differential spots were selected when considering at least 100% of volume variation between matching spots in all three distinct comparative experiments.
In-Gel Trypsin Digestion and Analysis by Mass Spectrometry Protein spots were in-gel digested by manually as Shevchenko A has reported.
11) Briefly, proteins were in-gel reduced in 10 mM DTT and alkylated by 55 mM iodoacetamide, gel spots were washed by alternatively dehydrating gel pieces and finally dehydrated in acrylonitrile and dried for 15 min. Gel pieces were further rehydrated for 15 min at room temperature in a 0.5 mM solution of modified bovine trypsin and samples were incubated for 2 h at 37.7°C. Adding 1% aqueous formic acid stopped the reaction; digests were desalted using Zip-Tips C18 (Millipore) and stepwise eluted in 50% and 100% acrylonitrile. The peptides mixture was solubilized with 0.5% TFA for mass spectrometry analysis. The desalted peptide mixture volume was concentrated in 2 ml of 1% aqueous formic acid. The extracted solutions were mixed in an Eppendorf tube, and dried in a vacuum concentrator. MS was performed on a liquid chromatography electrospray ionisation mass spectrometry/mass spectrometry (LTQ-ESI-MS/MS, ThermoFinnigan, San Jose, CA, U.S.A.), using a surveyor high-performance liquid chromatography (HPLC) system connected through PepFinder kit (with peptide trap and 99 : 1 flow splitter), the ion transfer capillary temperature was set at 170°C.
Database Searching and Functional Characterization of Identified Proteins Mass data collected during the LTQ-ESI-MS/MS analysis were processed and converted into a file using the Masslynx TM software (Micromass) to be submitted to the Mascot search software (http://www.matrixscience.com/). Identifications were obtained by comparison of experimental data with the NCBI non-redundant mammalian database and were validated when considering at least two peptide sequences per protein. The main cellular location and function of identified proteins, as well as their respective biological relationships, were searched and determined by going through PubMed (http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi) with EndNote software v.5.0.
Western Blotting Analysis of MRLC2 At the end of stimulation, cells were washed, scraped from dishes and lysed in PBS. Proteins (30 mg) were separated by electrophoresis in a 10% SDS-polyacrylamide gel. After the proteins were transferred onto a polyvinylidene difluoride membrane (Millipore, Bedford, MA, U.S.A.), the blot was incubated with blocking buffer (1ϫPBS and 5% non-fat dry milk) for 1 h at room temperature and then probed with anti-MRLC2 (1 : 200) monoclonal antibody, followed by incubation with secondary antibody, horseradish peroxidase conjugated affinity goat anti-mouse IgG (1 : 10000) for 1 h. To control equal loading of total protein in all lanes, blots were stained with mouse anti b-actin antibody at a 1 : 10000 dilution. The bound immunoproteins were detected by enhancer chemiluminescent assay (ECL; Amersham), and the intensities were quantified with a densitometric analysis (Digital Protein DNA Imagineware, Huntington Station, NY, U.S.A.).
Statistical Analysis Results are presented as meansϮ standard error of the meansϮS.E. Statistical significance of the differences between experimental groups was calculated by unpaired Student's t-test, pϽ0.05 was considered to be statistically significant.
RESULTS
Effect of Ouabain on Cell Viability in HUVEC
To test the effect of ouabain on HUVEC viability, the cells were treated for 12, 24 and 48 h with various concentrations of ouabain (0.1, 0.5, 1, 5, 10, 20, 40, 100 nM) in a cell culture medium containing 10% (v/v) FBS. Cells growing on 96-well plates were treated with the indicated concentrations of ouabain at different intervals (Fig. 1A) , MTT results showed that the ouabain played a bifunctional role on growth of HUVEC, it increased HUVEC cell number when exposed to concentrations р20 nM and induced cell apoptosis at higher concentrations. Using the trypan blue exclusion assay, an increase in cell number up to 40% of HUVEC treated with 10 nM ouabain was observed when compared with the control group (pϽ0.01) as showed in Fig. 1B .
The Morphological Changes of HUVEC Exposed to Ouabain To support these results, we performed electronic microscope analysis of HUVEC treated and not treated with ouabain, the common features ( Fig. 2A) and ouabain treated cells were observed under a transmission electronic microscope, cell proliferation were observed in 10 nM ouabain at 24 h (Fig. 2B ) while apoptosis were induced in 100 nM ouabain treated for 24 h (Fig. 2C) 
2-DE and Mass Spectrometry
To further investigate the role of the inductive effect of low-dose ouabain on HUVEC proliferation, we pursued comparative proteomics analysis of endothelial cells in response to low-dose ouabain. Computer-assisted spot matching and silver staining images of the two gels, enabled localization of variation spots. Spots detected by silver staining were excised and subjected to for identification. In our experiments, we got the 2-DE of lowdose ouabain treated HUVEC (Fig. 3B ) and control HUVEC (Fig. 3A) ; at least three 2-D gels were run per sample. Over 2800 protein spots visualized, 32 that were differentially expressed in two groups were identified by LTQ-ESI-MS/MS, as shown in Fig. 4 and Table 1 , the identified proteins involved in various aspect of endothelial cellular function, including metabolism, cell motility and signal transduction as well. Among these proteins, in comparison with controls cells, the differential proteomic analysis of HUVEC treated by ouabain further revealed the variation of eight proteins, namely, Annexin A1, Annexin A2, Malate dehydrogenase, Myosin regulatory light chain 2, Profilin-1, S100 calciumbinding protein A13, Thioredoxin and Translationally controlled tumor protein (Table 2 ). Five proteins were over-expressed; they are Annexin A1, Annexin A2, Malate dehydrogenase, Myosin regulatory light chain 2 and Profilin-1, while three proteins were down-regulated, namely, S100 calciumbinding protein A13, Thioredoxin, and Translationally controlled tumor protein. 
Effect of Low-Dose Ouabain on the Expression of MRLC2
To conform the results of 2-DE and study the expression of MRLC2 in low-dose ouabain treated HUVEC, we carried out western blot analysis of MRLC2, and lowdose ouabain increased the expression of MRLC2 (pϽ0.01), meet the result of 2-DE as shown in Fig. 5 . 
DISCUSSION
Ouabain, a digitalis compound, can regulate many cellular events such as growth and proliferation. It modulates NKA activity leading to the activation of different intracellular pathways through protein-protein interactions that have been characterized during the last few years. Recent observations suggest that ouabain has additional effects on cardiac cell function besides its positive inotropic action, the inductive effect on cell proliferation with low concentrations of ouabain has been observed in studies mainly with ouabain in cell cultures of vascular smooth muscle of rat and dog, and recently in humans, 5, 12) as well as in human prostate smooth muscle cells. 4) Furthermore, evidence was provided that ouabain exerts dual effects (proliferation and apoptosis) on cell growth, a stimulating effect on cell proliferation has been observed at concentrations less than 10 nM, and ouabain at the concentrations are ineffective or only slightly affect the Na ϩ /K ϩ exchange, while at concentrations above 10 nM, an inhibitory effect on cell growth is produced. 4, 5, 7) Although the proliferation induced by the NKA inhibitors such as ouabain has been known for many years, the mechanism of this action was not well defined. 7, 8) Since the vascular endothelium could be a potential target of endogenous ouabain, we investigated the effect of ouabain on proliferation in HUVEC.
In cell viability assay, we observed that ouabain stimulated cell proliferation and increased cell viability at low concentrations, also the stimulation of cell proliferation at concentrations below 10 nM and induction of apoptosis at higher concentrations were confirmed by TEM, similar biphasic behavior has been shown in the ouabain-induced mitogenic effect on VSMC 12) as well as in human prostate smooth muscle cells. 13) To further investigate the effect of low-dose ouabain on endothelial cell proliferation, we compared different protein expression of the ouabain-treated HUVEC with control group. Despite the fact that 2-DE probably did not allow the efficient separation of the majority of hydrophobic proteins such as membrane receptors or proteins from the mitochondria, 14) the functional characterization of the identified proteins illustrate some morphological and biological features of the effect of ouabain, such as cell contractility, accommodate of Ca 2ϩ , cellular metabolism, signal transduction, resistance to chemical or physical "stress," and antigen processing by proteasome (Fig. 4, Tables 1, 2) . Ren reported the results of mRNA profile analysis of HUVEC with ouabain treatment at pathological concentrations (0.9-1.8 nmol/l), 15) the regulated genes were not accordance with the proteins identified in this experiment, we think the discrepancy may be due to cell type, the concentration of ouabain and the techniques used. On the other hand, the regulated genes identified using mRNA profiling were related to signal transduction and metabolism, the differential proteomic analysis of HUVEC treated by low-dose ouabain further revealed the variation of eight proteins involved in the various cellular functions more related to cell mobility, signal transduction and proliferation, this new information also expand our understanding of the effect of ouabain on HUVEC at different concentrations.
It is well known that endogenous digitalis-ouabain plays its role by inhibiting the a1 isoform of NKA, strikingly, one of the identified proteins expressed differently in ouabaintreated HUVEC, translationally controlled tumor protein (TCTP), also a NKA-binding protein serving as an intracellular inhibitor of NKA activity, acts on the cytoplasmic side of the cell membrane. 16) It has been shown to bind to tubulin in the cytoskeleton and is thought to be controlled at the translational as well as the transcriptional level. 17) Furthermore, we identified proteins implicated in signal transduction and membranes, with a large representation of multifunctional annexins and S100A13, also support the idea that ouabain can develop its signal transduction functions without inhibit NKA. Annexin A1 plays a key role in mediating the effects of hormones and drugs on the immune and neuro-endocrine systems involved in signal transduction. 18 ) Annexin A2 has been implicated in a number of biochemical processes, including cell proliferation, ion-channel activation, cell-cell interactions and the bridging of membranes. 19, 20) At the same time, Human S100A13, a ubiquitous protein involved in the cellular export of interleukin-1a (IL1a) and fibroblast growth factor-1 (FGF-1), plays a crucial role in angiogenesis and tissue regeneration. 21) In addition, the expression of thioredoxin and malate dehydrogenase, which are related to nitrogen metabolism as components of the tricarboxylic acid cycle were also regulated, and this might also induce NO production. Thioredoxin, involved in the first unique step in DNA synthesis, also provides control over a number of transcription factors affecting cell proliferation and death through a mechanism referred to as redox regulation, 22) more interesting, among the finally thioredoxins activate numerous target enzymes by reduction of disulfides, one of these target enzymes is the NADP-dependent malate dehydrogenase. 23) Thus, it is conceivable that alterations in these proteins might stimulate the cell growth and metabolism of HUVEC.
Meanwhile, we got the variation of profilin-1 and myosin regulatory light chain 2 (MRLC2), though profilin-1 is thought to play a key role in the regulation of actin dynamics, 24, 25) there is growing evidence that, apart from actin binding, it acts as hubs that control a complex network of molecular interactions involved in membrane trafficking, small-GTPase signaling and nuclear activities, and plays a pivotal role at the interface of the phosphoinositide signal transduction pathway and the cytoskeleton. 26) MRLC2, 27, 28) which was found to be up regulated in the present study, has important effect on cell contraction and signaling pathway. Recent research paid more interest in the role of myosin regulatory light chain 2 in actin reorganization. 29, 30) Therefore, in the present paper, we only focused on MRLC2, in our experiment, we found that MRLC2 was up-regulated in the treatment of low doses of ouabain and the western blot assay obtained results similar to 2-DE, the expression of MRLC2 increased in the low doses of ouabain-treated HUVEC compared with control group, and the unregulated MRLC2 played an important role in the HUVEC proliferation without the inhibition of NKA. Further work is underway.
Taken together, we found digitalis played its role in the cell proliferation, cell motility, signal transduction and other cellular processes in endothelia cells by different means, the identified proteins offer possible sites for therapeutic intervention and provide new rationale for development of new pharmacological therapies, it may in fact be possible to develop new agents that act at the cellular level to produce positive therapeutic actions but with a reduced incidence of toxicity. Studies in great depth on all these proteins will provide a better understanding of digitalis and provide new strategies to fighting cardiovascular diseases.
